Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01896661Phase 3Completed
Phase 3, randomised, double-blind trial of chlorthalidone and amiloride in hypertension (HTN) and obstructive sleep apnea (OSA) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoints: Apnea-Hypopnea Index at 8 weeks and Blood Pressure at 8 weeks. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01896661.